KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cardlytics (CDLX) Net Margin (2017 - 2025)

Cardlytics (CDLX) has disclosed Net Margin for 9 consecutive years, with 14.71% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Margin rose 636.0% year-over-year to 14.71%, compared with a TTM value of 44.36% through Dec 2025, up 2366.0%, and an annual FY2025 reading of 44.36%, up 2366.0% over the prior year.
  • Net Margin was 14.71% for Q4 2025 at Cardlytics, up from 139.67% in the prior quarter.
  • Across five years, Net Margin topped out at 48.64% in Q1 2022 and bottomed at 458.5% in Q4 2022.
  • Average Net Margin over 5 years is 70.03%, with a median of 30.49% recorded in 2023.
  • The sharpest move saw Net Margin tumbled -44536bps in 2022, then skyrocketed 34542bps in 2023.
  • Year by year, Net Margin stood at 13.14% in 2021, then crashed by -3389bps to 458.5% in 2022, then skyrocketed by 75bps to 113.09% in 2023, then soared by 81bps to 21.07% in 2024, then surged by 30bps to 14.71% in 2025.
  • Business Quant data shows Net Margin for CDLX at 14.71% in Q4 2025, 139.67% in Q3 2025, and 14.68% in Q2 2025.